Be the first to review this product
AdTab dog
AdTab dog
AdTab chewable tablets for dogs protect against fleas and ticks.
Functioning
AdTab for dogs kills existing ticks within 8 hours and existing fleas within 6 hours. AdTab has an immediate and sustained killing effect for 1 month against fleas (Ctenocephalides felis and C. canis) and ticks (Rhipicephalus sanguineus, Ixodes ricinus, I. hexagonus, and Dermacentor reticulatus). Fleas and ticks must attach to the host and begin feeding to be exposed to the active ingredient lotilaner.
Administration
An AdTab chewable tablet needs to be administered only once a month. Additionally, the tablet is small and has a meaty flavor, making it easy to administer and quickly absorbed. The chewable tablet should be given with food or after feeding.
AdTab is suitable from 8 weeks of age and for puppies weighing 1.3 kg or more.
Patient Information Leaflet
Read the patient information leaflet before use.
AdTab dog
AdTab chewable tablets for dogs protect against fleas and ticks.
Functioning
AdTab for dogs kills existing ticks within 8 hours and existing fleas within 6 hours. AdTab has an immediate and sustained killing effect for 1 month against fleas (Ctenocephalides felis and C. canis) and ticks (Rhipicephalus sanguineus, Ixodes ricinus, I. hexagonus, and Dermacentor reticulatus). Fleas and ticks must attach to the host and begin feeding to be exposed to the active ingredient lotilaner.
Administration
An AdTab chewable tablet needs to be administered only once a month. Additionally, the tablet is small and has a meaty flavor, making it easy to administer and quickly absorbed. The chewable tablet should be given with food or after feeding.
AdTab is suitable from 8 weeks of age and for puppies weighing 1.3 kg or more.
Patient Information Leaflet
Read the patient information leaflet before use.
Read the leaflet before use.
Animal | Dog, Puppy |
Prescription required Netherlands | No |
Prescription required Germany | No |
Prescription required France | |
Prescription required Spain | |
Further information |